SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotechnology Value Fund, L.P.
An SI Board Since January 1998
Posts SubjectMarks Bans
4974 145 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromPosted
4074European Commission Approves Innovative First-in-Class Treatment for a Serious Cscaram(o)uche10/28/2004
4073OTish Spitzer, Hedge Fund stories from WSJ: Message 20692134 and following poDoc Bones10/27/2004
4072Bayer and Onyx Announce Positive Phase II Data in Patients With Advanced Kidney scaram(o)uche10/25/2004
4071>>INDs are no longer <b>perceived</b> as value drivers<<tuck10/18/2004
4070>> this ain't 2000 anymore << Two responses come to mind. wellscaram(o)uche10/18/2004
4069The Scientist chimes in with its take on the current state of biotech financing.tuck10/18/2004
4068Tom: I can't stop promotion-oriented dweebs from posting to the thread. Ifscaram(o)uche10/16/2004
4067oh, dear. Watch for the incoming.tom pope10/16/2004
4066<b> MTXX = fastest growing OTC pharmaceutical </b> earnings watch, Bo Didley10/16/2004
4065thanks for posting that! (eom)scaram(o)uche10/15/2004
406411:41 ET Cotherix IPO opens at $6.01, after pricing poorly (CTRX) 6.04 +0.04: Cosjemmeri10/15/2004
4063List of current IPO filings courtesy of tuck: Message 20614183sjemmeri10/8/2004
4062Genentech Announces Third Quarter 2004 Results Wednesday October 6, 4:12 pm ET scaram(o)uche10/6/2004
4061Message 20602855scaram(o)uche10/5/2004
4060Thanks, rkrw, for planting that beauty here. We had Genetics Institute in-housescaram(o)uche10/5/2004
4059Fascinating. It would have been easy to think "who needs these headaches?&qBiomaven10/5/2004
4058Courtesy of a yahoo mb post. Just pre epo introduction with amgn "hemorrhagrkrw10/4/2004
4057Biotech's Q3 Fundraising Brings the Year-to-Date Total to More Than $20 Billscaram(o)uche10/4/2004
4056Vicuron Pharmaceuticals Announces Pricing of $70.8 Million Public Offering KINGnigel bates9/30/2004
4055ARIUS Completes Private Placement with U.S.-Based Biotechnology Value Fund L.P. scaram(o)uche9/28/2004
4054<<<Didn't the old Liposome Company already try liposome dox in brearkrw9/26/2004
4053Specifics I can't dredge, but it is a project -- or a wrinkle on such -- thascaram(o)uche9/24/2004
4052<<>> liposome-encapsulated doxorubicin-citrate complex << DidMichael Young9/24/2004
4051>> liposome-encapsulated doxorubicin-citrate complex << Sounds likescaram(o)uche9/24/2004
4050<i>monies that are landing in private biotechs.... cash continues to wash nigel bates9/24/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News